{"id":19902,"date":"2015-06-25T11:05:41","date_gmt":"2015-06-25T09:05:41","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=19902"},"modified":"2015-06-25T11:05:41","modified_gmt":"2015-06-25T09:05:41","slug":"farmaci-generici-salerno-reforming-potenziali-elevati-ma-servono-ulteriori-ricerche","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/farmaci-generici-salerno-reforming-potenziali-elevati-ma-servono-ulteriori-ricerche\/","title":{"rendered":"Generic drugs, Salerno (Reforming): high potential but further research is needed"},"content":{"rendered":"

\"COVERHP\"There are potentials for faster generic entry and increased competition but there is also a need for further research into the generic market and the most efficient policy mix that could maximize generic entry and penetration. These are some of the policy implications highlighted by a study entitled "Performance measurement in the off-patent market<\/span><\/a>\u201d published by Elsevier Ireland.<\/p>\n

The study dates back to the end of 2014 and was referred to by the Reforming.it website, the portal of which it is the promoter Nicholas Salerno<\/b>, an economist known to the supply chain for his pro-liberalization positions. The reflection carried forward by the Reforming website, in quoting the article, is that \u00abachieving full efficiency in the production and distribution of \u201ctraditional\u201d medicines is essential in order to have sufficient structural resources to support innovative and biotechnological medicines. This virtuous circle is far from being established in the governance system of the Italian pharmaceutical sector\u00bb.<\/p>\n

Furthermore, the dynamics of prices are highlighted: \u00abjust after the patent expiry, the drop in originator prices is significant and greater than in the rest of Europe. However, the prices of the originators end up more or less aligning themselves with the prices of the equivalents, and at the same time, they fall much less (compared to the price before the loss of exclusivity) than in the rest of Europe\u00bb.<\/p>\n

\"\"And "the level of market penetration of equivalents and biosmilars remains much lower in Italy than in most of the member states". But limiting oneself to "only considering the price differential, before and after the patent expiry, can be misleading in assessing market competition and in suggesting pharmaceutical policies".<\/p>\n

From the study comes the proposal of a model of five indicators and a series of measurement methods and mechanisms that allow the performance evaluation of generics policies in the various systems characterized by different settings and choices: availability of generics, delay or speed of entry of the generics, number of competitors, price evolution, and trends in the volume share of generics.<\/p>\n

"The range of each of the five indicators" reads the study "suggests that there are numerous factors - including institutional ones - that contribute to the success of generic entry, price decreases and market penetration". But the spaces to enhance the situation "seem to exist".<\/p>\n

Francesca Giani \u2013 Thursday, 25 June 2015 \u2013 Pharmacist33<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"

Ci sono potenziali rispetto a un pi\u00f9 veloce ingresso del generico sul mercato e a una maggiore competizione ma c’\u00e8 anche bisogno di ulteriori ricerche inerenti al mercato del generico e sul mix di politiche pi\u00f9 efficienti che potrebbero massimizzarne l’ingresso e la penetrazione. Sono queste alcune delle implicazioni sulle politiche messe in luce da …<\/p>","protected":false},"author":4,"featured_media":3749,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[31],"class_list":["post-19902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-generici"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/19902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=19902"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/19902\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/3749"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=19902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=19902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=19902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}